MedTrace Logo

Nonradiation-to-endoscopist Endoscopic Retrograde Cholangiopancreatography in Patients With Complexity Level I/II

NCT02697149 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219

Last updated 2016-07-21

No results posted yet for this study

Summary

Radiation exposure may put endoscopists at risk when performing endoscopic retrograde cholangiopancreatography. Although non-radiation endoscopic retrograde cholangiopancreatography was reported in pregnant women in previous reports, it remains unclear whether endoscopic retrograde cholangiopancreatography is also effective and safe when endoscopists were not expose to radiation. This study was to evaluate the effectiveness and safety of nonradiation-to-endoscopist endoscopic retrograde cholangiopancreatography in patients with complexity level I/II.

Conditions

  • Endoscopic Retrograde Cholangiopancreatography , Gallstone

Interventions

RADIATION

nonradiation-to-endoscopist endoscopic retrograde cholangiopancreatography

All patients received magnetic resonance cholangiopancreatography before the procedure. Characteristics of lesions (e.g. common bile duct stones, stenosis) in detail was identified. During the procedure, the endoscopist was not exposed to radiation. If fluoroscopy was needed, after contrast injection (sometimes not necessary), the endoscopist went outside of the operation room and observed the X-ray image by remote control of the fluoroscopy machine.

RADIATION

standard endoscopic retrograde cholangiopancreatography

Patients received standard endoscopic retrograde cholangiopancreatography. Fluoroscopy was normally used when necessary.

Sponsors & Collaborators

  • Air Force Military Medical University, China

    lead OTHER

Principal Investigators

  • Yanglin Pan, M.D. · Air Force Military Medical University, China

  • Wei Zeng, M.D. · Department of gastroenterology, Chinese PLA 174 hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02697149 on ClinicalTrials.gov